Skip Navigation

European Heart Journal 2002 23(5):426-427; doi:10.1053/euhj.2001.3084
Copyright © 2002 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Remme, W.
Right arrow Articles by Swedberg, K.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Remme, W.
Right arrow Articles by Swedberg, K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Letters to the Editor

A reply

W. Remme, Co-Chairmen, Task Force Guidelines for the diagnosis and treatment of chronic heart failure and K. Swedberg, Co-Chairmen, Task Force Guidelines for the diagnosis and treatment of chronic heart failure

References

  1. Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Eur Heart J. 2001;22:1527–1560[Free Full Text]
  2. Pitt B, Zannad F, Remme WJ. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med. 1999;341:709–717[Abstract/Free Full Text]
  3. Krum H, Sackner-Bernstein JD, Goldsmith RL. Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure. Circulation. 1995;92:1499–1506[Abstract/Free Full Text]
  4. Metra M, Giubbini R, Nodari S, Boldi E, Modena MG, Dei Cas L. Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol. Circulation. 2000;102:546–551[Abstract/Free Full Text]
  5. Kukin ML, Kalman J, Charney RH. Prospective, randomized comparison of effect of long-term treatment with metoprolol or carvedilol on symptoms, exercise, ejection fraction, and oxidative stress in heart failure. Circulation. 1999;99:2645–2651[Abstract/Free Full Text]
  6. Metra M, Nardi M, Giubbini R, Dei Cas L. Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idiopathic dilated cardiomyopathy. J Am Cardiol. 1994;24:1678–1687
  7. Sanderson JE, Chan SK, Yip G. Beta-blockade in heart failure: a comparison of carvedilol with metoprolol. J Am Coll Cardiol. 1999;34:1522–1528[Abstract/Free Full Text]
  8. Gullestad L, Manhenke C, Aarsland T. Effect of metoprolol CR/XL on exercise tolerance in chronic heart failure—a substudy to the MERITHF trial. Eur J Heart Fail. 2001;3:463–468[CrossRef][ISI][Medline]
  9. Andersson B, Hamm C, Persson S. Improved exercise hemodynamic status in dilated cardiomyopathy after beta-adrenergic blockade treatment. J Am Coll Cardiol. 1994;23:1397–1404[Abstract]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Remme, W.
Right arrow Articles by Swedberg, K.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Remme, W.
Right arrow Articles by Swedberg, K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?